Medicaid Services Investment and Accountability Act of 2019
Official title: To amend title XIX to extend protection for Medicaid recipients of home and community-based services against spousal impoverishment, establish a State Medicaid… Show full official titleShow less
Official title: To amend title XIX to extend protection for Medicaid recipients of home and community-based services against spousal impoverishment, establish a State Medicaid option to provide coordinated care to children with complex medical conditions through health homes, prevent the misclassification of drugs for purposes of the Medicaid drug rebate program, and for other purposes.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Became Public Law No: 116-16.
Medicaid Services Investment and Accountability Act of 2019
This bill alters several Medicaid programs and funding provisions.
(Sec. 2) The bill temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home- and community-based services.
(Sec. 3) The bill also establishes a state Medicaid option to provide for medical assistance with respect to coordinated care provided through a health home (i.e., a designated provider or team of health-care professionals) for children with medically complex conditions. States must determine payment methodologies in accordance with specified requirements; payments also temporarily qualify for an enhanced federal matching rate.
(Sec. 4) The bill also temporarily extends the Medicaid demonstration program for certified community behavioral health clinics.
(Sec. 5) The bill increases funding available to the Money Follows the Person Rebalancing Demonstration Program. (Under this program, the Centers for Medicare & Medicaid Services may award grants to state Medicaid programs to assist states in increasing the use of home and community care for long-term care and decreasing the use of institutional care.)
(Sec. 6) Further, drug manufacturers with Medicaid rebate agreements for covered outpatient drugs must disclose drug product information. Manufacturers are subject to civil penalties for knowingly misclassifying drugs. Manufacturers are also required to compensate for rebates that were initially underpaid as a result of misclassification (whether or not such misclassification was committed knowingly).
- Engrossed in House Formatted Text PDF Formatted XML
- Enrolled Bill Formatted Text PDF Formatted XML
- Introduced in House Formatted Text PDF Formatted XML
- Public Law Formatted Text PDF United States Legislative Markup
- Received in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 1839: Medicaid Services Investment and Accountability Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-1839/
"H.R. 1839: Medicaid Services Investment and Accountability Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-1839/.
H.R. 1839, 116th Cong. (2026), https://openamerica.io/bill/116-HR-1839/.
[H.R. 1839: Medicaid Services Investment and Accountability Act of 2019](https://openamerica.io/bill/116-HR-1839/)